相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment
Correne A. DeCarlo et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
A Genetic Variant in the Promoter Region of Toll-Like Receptor 9 and Cervical Cancer Susceptibility
Xiaojun Chen et al.
DNA AND CELL BIOLOGY (2012)
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo
Norliana Khairuddin et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
Cristina Mansilla et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Involvement of toll-like receptor 9 polymorphism in cervical cancer development
Andrzej Roszak et al.
MOLECULAR BIOLOGY REPORTS (2012)
Treatment of Cervical Intraepithelial Neoplasia With Topical Imiquimod A Randomized Controlled Trial
Christoph Grimm et al.
OBSTETRICS AND GYNECOLOGY (2012)
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
Nathalie Garcon et al.
BIODRUGS (2011)
The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA
Peter Oehlschlaeger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Association between toll-like receptor expression and human papillomavirus type 16 persistence
Ibrahim I. Daud et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Toll-Like Receptors Expressed by Dermal Fibroblasts Contribute to Hypertrophic Scarring
Jianfei Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility
Saumya Pandey et al.
MOLECULAR BIOLOGY REPORTS (2011)
Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes
Rezaul Karim et al.
PLOS ONE (2011)
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells
Xian-Zhen Chen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Gerty Schreibelt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia
Li Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes
Correne A. DeCarlo et al.
LABORATORY INVESTIGATION (2010)
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
Ivan Hirsch et al.
TRENDS IN IMMUNOLOGY (2010)
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
Chao-Yi Wu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Toll-like receptors and innate immunity
Himanshu Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pathogen recognition in the innate immune response
Himanshu Kumar et al.
BIOCHEMICAL JOURNAL (2009)
Expression of Foxp3+CD4+CD25+regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum
Y. Xu et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
John A. Thompson et al.
CLINICAL GENITOURINARY CANCER (2009)
Impact of Toll-like receptors [TLR] 2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women
Saumya Pandey et al.
GYNECOLOGIC ONCOLOGY (2009)
Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
Chi-Mu Chuang et al.
HUMAN GENE THERAPY (2009)
Imiquimod inhibits the differentiation but enhances the maturation of human monocyte-derived dendritic cells
Ke-Jian Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
Laura M. Fahey et al.
JOURNAL OF IMMUNOLOGY (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Clinician's guide to human papillomavirus immunology: knowns and unknowns
Mark H. Einstein et al.
LANCET INFECTIOUS DISEASES (2009)
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex
Beom Seok Park et al.
NATURE (2009)
Cellular binding partners of the human papillomavirus E6 protein
Sandy S. Tungteakkhun et al.
ARCHIVES OF VIROLOGY (2008)
Overexpression of Toll-like Receptors 3 and 4 in Synovial Tissue From Patients With Early Rheumatoid Arthritis Toll-like Receptor Expression in Early and Longstanding Arthritis
Caroline Ospelt et al.
ARTHRITIS AND RHEUMATISM (2008)
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production
Friederike Meyer-Wentrup et al.
BLOOD (2008)
Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
Qun Jiang et al.
BMC CANCER (2008)
The antiviral activity of toll-like receptor 7 and 7/8 agonists
Richard L. Miller et al.
DRUG NEWS & PERSPECTIVES (2008)
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia
W. Y. Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
Olivier Manches et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma
Maja A. Hofmann et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata
U. Meyer-Hoffert et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
You-Me Kim et al.
NATURE (2008)
Treatment of vulvar intraepithelial neoplasia with topical imiquimod
Manon van Seters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Polymorphisms in Toll-like receptor genes and risk of cancer
E. M. El-Omar et al.
ONCOGENE (2008)
Structural basis of toll-like receptor 3 signaling with double-stranded RNA
Lin Liu et al.
SCIENCE (2008)
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Michel Gilliet et al.
NATURE REVIEWS IMMUNOLOGY (2008)
CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCγ2
Juergen Roeck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2
Nicholas Funderburg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
J. Visser et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Histamine amplifies immune response of gingival fibroblasts
T. Minami et al.
JOURNAL OF DENTAL RESEARCH (2007)
Increased toll-like receptor 9 expression in cervical neoplasia
Jeong-Won Lee et al.
MOLECULAR CARCINOGENESIS (2007)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non-hodgkin's lymphoma
John R. Leonard et al.
CLINICAL CANCER RESEARCH (2007)
CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
Johan W. Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
BDCA2/FcεRlγ complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells
Wei Cao et al.
PLOS BIOLOGY (2007)
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide
Mi Sun Jin et al.
CELL (2007)
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran
Ho Min Kim et al.
CELL (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling
Melanie M. Brinkmann et al.
JOURNAL OF CELL BIOLOGY (2007)
New hepatitis B vaccine formulated with an improved adjuvant system
Michael Kundi
EXPERT REVIEW OF VACCINES (2007)
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16
Uzma A. Hasan et al.
JOURNAL OF IMMUNOLOGY (2007)
Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells
HY Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Innate immunity at the mucosal surface: Role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens
JM Andersen et al.
BIOLOGY OF REPRODUCTION (2006)
Human α-defensins block papillomavirus infection
CB Buck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection
RM Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
H Häcker et al.
NATURE (2006)
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
G Oganesyan et al.
NATURE (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells
JM Roda et al.
JOURNAL OF IMMUNOLOGY (2005)
Detection of human papillomavirus (HPV) 16-specific CD4+T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment
MIE van Poelgeest et al.
CLINICAL CANCER RESEARCH (2005)
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88
RC Yang et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus
J Schlender et al.
JOURNAL OF VIROLOGY (2005)
IRF-7 is the master regulator of type-I interferon-dependent immune responses
K Honda et al.
NATURE (2005)
MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection
SH Zhou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles
HJ Bontkes et al.
GYNECOLOGIC ONCOLOGY (2005)
Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-κB-mediated signalling, moderated by TGF-β
MY Yan et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
被撤回的出版物: Expression and function of Toll-like receptor on T cells (Retracted article. See vol. 281, pg. 170, 2013)
D Xu et al.
CELLULAR IMMUNOLOGY (2005)
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
D Tudor et al.
VACCINE (2005)
Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A
L Tiberio et al.
VACCINE (2004)
Toll-like receptors and acquired immunity
C Pasare et al.
SEMINARS IN IMMUNOLOGY (2004)
Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6
T Kawai et al.
NATURE IMMUNOLOGY (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10
B He et al.
JOURNAL OF IMMUNOLOGY (2004)
Inferences, questions and possibilities in toll-like receptor signalling
B Beutler
NATURE (2004)
Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells
MY Yan et al.
VIROLOGY (2004)
Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments
A Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanisms of human papillomavirus-induced oncogenesis
K Münger et al.
JOURNAL OF VIROLOGY (2004)
Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling
K Honda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain
JC Bambou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells
A Izaguirre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein
YM Zhang et al.
JOURNAL OF VIROLOGY (2003)
Defensins: Antimicrobial peptides of innate immunity
T Ganz
NATURE REVIEWS IMMUNOLOGY (2003)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A
M Martin et al.
INFECTION AND IMMUNITY (2003)
Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance, to uropathogenic Escherichia coli
JD Schilling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cutting edge:: A novel toll/IL-1 receptor Domain containing adapter that preferentially activates the IFN-β promoter in the toll-like receptor signaling
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2002)
Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2
A Biragyn et al.
SCIENCE (2002)
Human papillomavirus virus-like particles do not activate langerhans cells: A possible immune escape mechanism used by human papillomaviruses
SC Fausch et al.
JOURNAL OF IMMUNOLOGY (2002)
The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris
K Conner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells
MW Hornef et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Murine retroviruses activate B cells via interaction with toll-like receptor 4
JC Rassa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The interferon-α/β system in antiviral responses:: a multimodal machinery of gene regulation by the IRF family of transcription factors
T Taniguchi et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Bacterial lipopolysaccharide, TNF-α, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NF-κB
LA Lyakh et al.
JOURNAL OF IMMUNOLOGY (2000)
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome
M Frisch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate
SA Feldman et al.
JOURNAL OF VIROLOGY (2000)
分享论文
